MARINUS PHARMACEUTICALS, INC. Quarterly Deferred Tax Assets, Valuation Allowance in USD from Q4 2013 to Q4 2023

Taxonomy & unit
us-gaap: USD
Description
Amount of deferred tax assets for which it is more likely than not that a tax benefit will not be realized.
Summary
Marinus Pharmaceuticals, Inc. quarterly Deferred Tax Assets, Valuation Allowance history and growth rate from Q4 2013 to Q4 2023.
  • Marinus Pharmaceuticals, Inc. Deferred Tax Assets, Valuation Allowance for the quarter ending December 31, 2023 was $167M, a 35.4% increase year-over-year.
Deferred Tax Assets, Valuation Allowance, Quarterly (USD)
Deferred Tax Assets, Valuation Allowance, YoY Quarterly Growth (%)
Period Value YoY Chg Change % Date Report Filed
Q4 2023 $167M +$43.7M +35.4% Dec 31, 2023 10-K 2024-03-05
Q4 2022 $123M +$7.71M +6.67% Dec 31, 2022 10-K 2024-03-05
Q4 2021 $116M +$23.5M +25.5% Dec 31, 2021 10-K 2023-03-09
Q4 2020 $92.2M +$39.7M +75.7% Dec 31, 2020 10-K 2022-03-24
Q4 2019 $52.5M +$7.85M +17.6% Dec 31, 2019 10-K 2021-03-09
Q4 2018 $44.6M +$1.98M +4.64% Dec 31, 2018 10-K 2020-03-16
Q4 2017 $42.6M -$12.9M -23.3% Dec 31, 2017 10-K 2019-03-12
Q4 2016 $55.6M +$13.5M +32.1% Dec 31, 2016 10-K 2018-03-07
Q4 2015 $42.1M +$12.3M +41.2% Dec 31, 2015 10-K 2017-03-13
Q4 2014 $29.8M +$3.94M +15.2% Dec 31, 2014 10-K 2016-03-07
Q4 2013 $25.9M Dec 31, 2013 10-K 2015-03-12
* An asterisk sign (*) next to the value indicates that the value is likely invalid.